QA: Bellicum Pharmaceuticals INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2016_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 96,890,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,882,000
3 remainder_Assets 56,634,000
4 LiabilitiesCurrent 7,445,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 944,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,672,000
9 ResearchAndDevelopmentExpense 33,561,000
10 remainder_Expenses 3,184,000
11 remainder_Revenues 282,000
12 remainder_NetIncome 587,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 160,406,000
1 Liabilities 8,389,000
2 Expenses 49,417,000
3 Revenues 282,000
4 StockholdersEquity 152,017,000
5 NetIncome -48,548,000
6 ComprehensiveNetIncome -48,548,000
7 BaseVar 109,540,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.35
9 EconomicCapitalRatio 3.93

Edgar->Model Mapping

Feature Distribution